Cover Image
市場調查報告書

多血小板血漿(PRP)市場分析:各產品(純、高白血球、高白血球纖維蛋白)、各用途(整形外科、美容整形、眼科手術、神經手術),及市場區隔預測

Platelet Rich Plasma (PRP) Market Analysis By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Application (Orthopedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 526090
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
多血小板血漿(PRP)市場分析:各產品(純、高白血球、高白血球纖維蛋白)、各用途(整形外科、美容整形、眼科手術、神經手術),及市場區隔預測 Platelet Rich Plasma (PRP) Market Analysis By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Application (Orthopedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), And Segment Forecasts, 2014 - 2025
出版日期: 2017年06月05日 內容資訊: 英文 100 Pages
簡介

本報告提供全球多血小板血漿(PRP)市場相關調查,市場概要和各產品,各用途,各地區趨勢,市場參與市場企業的競爭趨勢,簡介等彙整資料。

第1章 調查方法

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場區隔
  • 市場規模與成長預測
    • 促進要素分析
    • 阻礙要素分析
  • 優先的主要機會
  • 產業分析:波特
  • PESTEL分析

第4章 各產品預測及趨勢分析

  • 趨勢分析及市場佔有率
  • 純PRP
  • 高白血球PRP
  • 高白血球纖維蛋白

第5章 各用途預測及趨勢分析

  • 趨勢分析
  • 整形外科
  • 美容整形、皮膚科
  • 眼科手術
  • 神經手術
  • 一般外科
  • 其他

第6章 各地區預測

  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭環境

  • 策略架構
  • 企業簡介
目錄
Product Code: GVR-1-68038-869-5

The global platelet rich plasma market is expected to reach USD 647.1 million by 2025, according to a new report by Grand View Research, Inc. Growing prevalence of orthopedic diseases and increasing application of PRP in cosmetic surgery is propelling the demand for the market. Platelet-rich plasma has become one of the cutting-edge technologies for a number of medical applications including orthopedics, general surgery, cosmetic surgery, cardiovascular surgery, wound healing, and others.

Platelet rich plasma treatments aid in soft tissue healing and reduce the risk of post and preoperative bleeding. As a result, it is considered as one of the most significant treatment methods for the management of several chronic diseases. The most enticing fact about this treatment is that the procedure helps in regeneration of ligament and tendon fibers, which can possibly obviate the need for surgery and result in enormous growth of the PRP market during the forecast period.

Further key findings from the study suggest:

The market study suggests that pure PRP dominated the overall market in 2016 owing to its greater capability and suitability for bone regeneration and improved patient response due to less inflammation

However, leukocyte-rich PRP is expected to witness highest growth rate due to the presence of inductive properties that help in stimulation of healing processes. Treatment with leukocyte-rich PRP is anticipated to be one of the most favorable methods in the future for the treatment of soft tissue defects

Amongst the application segments, orthopedics occupied the largest share in 2016 as PRP injections aid in rapid augmentation of soft tissue healing process. Few orthopedic complications that have been treated successfully with PRP techniques include knee osteoarthritis, Achilles tendinopathy, lateral epicondylitis, rotator cuff tears, and ulnar collateral ligament

The cosmetic surgery and dermatology application segment is expected to grow at the highest growth rate during the forecast period as PRP injections trigger the production of new cells and promote collagen formation, which naturally tightens and smoothens the skin

North America dominated the regional segment with the largest revenue share in 2016, due to increasing orthopedic disorders & sport injuries and greater developments in the field of plasma therapy

Asia Pacific is expected to witness significant growth during the forecast period, primarily due to growing awareness regarding platelet rich plasma treatment, rising demand for cosmetic procedures, and booming medical tourism industry in the region

Some of the major companies operating in this market are T-Biotechnology (T-LAB); Arthrex, Inc.; Terumo BCT, Inc.; EmCyte Corporation; DePuy Synthes; Zimmer Biomet; Stryker; Glofinn Oy; DR. PRP AMERICA, LLC; and others.

Table of Content

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis
  • 1.3 Approaches for Market Estimation
    • 1.3.1 Approach 1: Demand analysis &bottom-up approach
    • 1.3.2 Approach 2: Top-down market estimation
    • 1.3.3 Approach 3: Commodity flow and bottom-up market estimation
    • 1.3.4 Approach 4: KoL perspective-based market sizing

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Platelet Rich Plasma Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Market Size and Growth Prospects
    • 3.2.1 Market driver analysis
    • 3.2.2 Market restraint analysis
  • 3.3 Key Opportunities Prioritized
  • 3.4 Industry Analysis Porter's
  • 3.5 PESTEL Analysis

Chapter 4 Platelet Rich Plasma Market: Product Estimates & Trend Analysis

  • 4.1 Platelet Rich Plasma Market: Product Movement Analysis, 2016 & 2025
  • 4.2 Pure PRP
    • 4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3 Leukocyte Rich PRP
    • 4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.4 Leukocyte Rich Fibrin
    • 4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Platelet Rich Plasma Market: Application Estimates & Trend Analysis

  • 5.1 Platelet Rich Plasma Market: Application Analysis, 2016 & 2025
  • 5.2 Orthopedics
    • 5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.3 Cosmetic Surgery and Dermatology
    • 5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.4 Ophthalmic Surgery
    • 5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.5 Neurosurgery
    • 5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.6 General Surgery
    • 5.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.7 Others
    • 5.7.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Platelet Rich Plasma Market: Regional Estimates & Trend Analysis, by Product& Application

  • 6.1 Platelet Rich Plasma Market Share by Region, 2016 & 2025
  • 6.2 North America
    • 6.2.1 U.S.
      • 6.2.1.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.2.1.2 Market estimates and forecasts, by application, 2014 - 2025
    • 6.2.2 Canada
      • 6.2.2.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.2.2.2 Market estimates and forecasts, by application, 2014 - 2025
  • 6.3 Europe
    • 6.3.1 UK
      • 6.3.1.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.3.1.2 Market estimates and forecasts, by application, 2014 - 2025
    • 6.3.2 Germany
      • 6.3.2.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.3.2.2 Market estimates and forecasts, by application, 2014 - 2025
  • 6.4 Asia Pacific
    • 6.4.1 China
      • 6.4.1.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.4.1.2 Market estimates and forecasts, by application, 2014 - 2025
    • 6.4.2 Japan
      • 6.4.2.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.4.2.2 Market estimates and forecasts, by application, 2014 - 2025
  • 6.5 Latin America
    • 6.5.1 Brazil
      • 6.5.1.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.5.1.2 Market estimates and forecasts, by application, 2014 - 2025
    • 6.5.2 Mexico
      • 6.5.2.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.5.2.2 Market estimates and forecasts, by application, 2014 - 2025
  • 6.6 MEA
    • 6.6.1 South Africa
      • 6.6.1.1 Market estimates and forecasts, by product, 2014 - 2025
      • 6.6.1.2 Market estimates and forecasts, by application, 2014 - 2025

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Company Profiles
    • 7.2.1 T-Biotechnology
      • 7.2.1.1 Company overview
      • 7.2.1.2 Financial performance
      • 7.2.1.3 Product benchmarking
      • 7.2.1.4 Strategic initiatives
    • 7.2.2 Arthrex, Inc.
      • 7.2.2.1 Company overview
      • 7.2.2.2 Financial performance
      • 7.2.2.3 Product benchmarking
      • 7.2.2.4 Strategic initiatives
    • 7.2.3 Terumo BCT, Inc.
      • 7.2.3.1 Company overview
      • 7.2.3.2 Financial performance
      • 7.2.3.3 Product benchmarking
      • 7.2.3.4 Strategic initiatives
    • 7.2.4 EmCyte Corporation
      • 7.2.4.1 Company overview
      • 7.2.4.2 Financial performance
      • 7.2.4.3 Product benchmarking
      • 7.2.4.4 Strategic initiatives
    • 7.2.5 DePuy Synthes
      • 7.2.5.1 Company overview
      • 7.2.5.2 Financial performance
      • 7.2.5.3 Product benchmarking
      • 7.2.5.4 Strategic initiatives
    • 7.2.6 Zimmer Biomet
      • 7.2.6.1 Company overview
      • 7.2.6.2 Financial performance
      • 7.2.6.3 Product benchmarking
      • 7.2.6.4 Strategic initiatives
    • 7.2.7 Stryker
      • 7.2.7.1 Company overview
      • 7.2.7.2 Financial performance
      • 7.2.7.3 Product benchmarking
      • 7.2.7.4 Strategic initiatives
    • 7.2.8 Glofinn OY
      • 7.2.8.1 Company overview
      • 7.2.8.2 Financial performance
      • 7.2.8.3 Product benchmarking
      • 7.2.8.4 Strategic initiatives
    • 7.2.9 Dr. PRP America
      • 7.2.9.1 Company overview
      • 7.2.9.2 Financial performance
      • 7.2.9.3 Product benchmarking
      • 7.2.9.4 Strategic initiatives

List of Tables

  • TABLE 1 Platelet rich plasma market - industry snapshot
  • TABLE 2 Platelet rich plasma market, by product, 2014 - 2025 (USD Million)
  • TABLE 3 Platelet rich plasma market, by application, 2014 - 2025 (USD Million)
  • TABLE 4 Platelet rich plasma market, by region, 2014 - 2025 (USD Million)
  • TABLE 5 Platelet rich plasma market: Key market driver analysis
  • TABLE 6 Platelet rich plasma market: Key market restraint analysis
  • TABLE 7 North America market, by product, 2014 - 2025 (USD Million)
  • TABLE 8 North America market, by application, 2014 - 2025 (USD Million)
  • TABLE 9 U.S. market, by product, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. market, by application, 2014 - 2025 (USD Million)
  • TABLE 11 Canada market, by product, 2014 - 2025 (USD Million)
  • TABLE 12 Canada market, by application, 2014 - 2025 (USD Million)
  • TABLE 13 Europe market, by product, 2014 - 2025 (USD Million)
  • TABLE 14 Europe market, by application, 2014 - 2025 (USD Million)
  • TABLE 15 UK market, by product, 2014 - 2025 (USD Million)
  • TABLE 16 UK market, by application, 2014 - 2025 (USD Million)
  • TABLE 17 Germany market, by product, 2014 - 2025 (USD Million)
  • TABLE 18 Germany market, by application, 2014 - 2025 (USD Million)
  • TABLE 19 Asia Pacific market, by product, 2014 - 2025 (USD Million)
  • TABLE 20 Asia Pacific market, by application, 2014 - 2025 (USD Million)
  • TABLE 21 Japan market, by product, 2014 - 2025 (USD Million)
  • TABLE 22 Japan market, by application, 2014 - 2025 (USD Million)
  • TABLE 23 China market, by product, 2014 - 2025 (USD Million)
  • TABLE 24 China market, by application, 2014 - 2025 (USD Million)
  • TABLE 25 Latin America market, by product, 2014 - 2025 (USD Million)
  • TABLE 26 Latin America market, by application, 2014 - 2025 (USD Million)
  • TABLE 27 Brazil market, by product, 2014 - 2025 (USD Million)
  • TABLE 28 Brazil market, by application, 2014 - 2025 (USD Million)
  • TABLE 29 Mexico market, by product, 2014 - 2025 (USD Million)
  • TABLE 30 Mexico market, by application, 2014 - 2025 (USD Million)
  • TABLE 31 MEA market, by product, 2014 - 2025 (USD Million)
  • TABLE 32 MEA market, by application, 2014 - 2025 (USD Million)
  • TABLE 33 South Africa market, by product, 2014 - 2025 (USD Million)
  • TABLE 34 South Africa market, by application, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Global Platelet rich plasma: Market segmentation
  • FIG. 2 Global Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 3 Platelet rich plasma: Market dynamics
  • FIG. 4 Platelet rich plasma market: Porter's analysis
  • FIG. 5 Key opportunities prioritized
  • FIG. 6 Platelet rich plasma market: PESTEL analysis
  • FIG. 7 Platelet rich plasma market share, by product, 2015 & 2025
  • FIG. 8 Pure PRP market, 2014 - 2025 (USD Million)
  • FIG. 9 Leukocyte rich PRP market, 2014 - 2025 (USD Million)
  • FIG. 10 Leukocyte rich fibrin market, 2014 - 2025 (USD Million)
  • FIG. 11 Platelet rich plasma market share, by application, 2015 & 2024
  • FIG. 12 Orthopedics market, 2014 - 2025 (USD Million)
  • FIG. 13 Cosmetic surgery & dermatology market, 2014 - 2025 (USD Million)
  • FIG. 14 Ophthalmic surgery market, 2014 - 2025 (USD Million)
  • FIG. 15 Neurosurgery market, 2014 - 2025 (USD Million)
  • FIG. 16 General surgery market, 2014 - 2025 (USD Million)
  • FIG. 17 Others market, 2014 - 2025 (USD Million)
  • FIG. 18 Platelet rich plasma market share, by region, 2015 & 2025
  • FIG. 19 North America Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 20 U.S. Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 21 Canada Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 22 Europe Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 23 UK Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 24 Germany Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 25 Asia Pacific Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 26 Japan Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 27 China Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 28 Latin America Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 29 Brazil Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 30 Mexico Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 31 MEA Platelet rich plasma market, 2014 - 2025 (USD Million)
  • FIG. 32 South Africa Platelet rich plasma market, 2014 - 2025 (USD Million
Back to Top